FDA notifications. Generic didanosine approved by FDA.
D016049:Didanosine / Q000627:therapeutic use; D016568:Drugs, Generic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D016049:Didanosine